tiprankstipranks
TransCode Therapeutics (RNAZ)
NASDAQ:RNAZ
US Market

TransCode Therapeutics (RNAZ) Technical Analysis

205 Followers

Technical Sentiment

Overall Consensus
Sell
4Bullish
5Neutral
13Bearish
Technical Analysis Consensus
Neutral
3Bullish
5Neutral
2Bearish
Moving Average Consensus
Strong Sell
1Bullish
0Neutral
11Bearish
TransCode Therapeutics’s (RNAZ) Moving Averages Convergence Divergence (MACD) indicator is -0.05, suggesting TransCode Therapeutics is a Buy.
TransCode Therapeutics’s (RNAZ) 20-Day exponential moving average is 1.11, while TransCode Therapeutics’s (RNAZ) share price is $0.94, making it a Sell.
TransCode Therapeutics’s (RNAZ) 50-Day exponential moving average is 1.16, while TransCode Therapeutics’s (RNAZ) share price is $0.94, making it a Sell.

TransCode Therapeutics (RNAZ) Pivot Points

Jul 03, 2024, 04:27 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
0.81
0.85
0.93
0.97
1.05
1.09
1.17
Fibonacci
0.85
0.90
0.93
0.97
1.02
1.05
1.09
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

TransCode Therapeutics (RNAZ) Moving Averages

Jul 03, 2024, 04:27 PM
Period
Simple
Exponential
MA5
1.01Sell
1.00Sell
MA10
1.02Sell
1.04Sell
MA20
1.15Sell
1.11Sell
MA50
1.06Sell
1.16Sell
MA100
0.86Buy
3.59Sell
MA200
6.49Sell
15.75Sell
TransCode Therapeutics’s (RNAZ) 10-Day exponential moving average is 1.04, while TransCode Therapeutics’s (RNAZ) share price is $0.94, making it a Sell.
TransCode Therapeutics’s (RNAZ) 100-Day exponential moving average is 3.59, while TransCode Therapeutics’s (RNAZ) share price is $0.94, making it a Sell.
TransCode Therapeutics’s (RNAZ) stock price is $0.94 and TransCode Therapeutics’s (RNAZ) 50-day simple moving average is 1.06, creating a Sell signal.
TransCode Therapeutics’s (RNAZ) stock price is $0.94 and TransCode Therapeutics’s (RNAZ) 100-day simple moving average is 0.86, creating a Buy signal.
TransCode Therapeutics’s (RNAZ) stock price is $0.94 and TransCode Therapeutics’s (RNAZ) 200-day simple moving average is 6.49, creating a Sell signal.

TransCode Therapeutics (RNAZ) Technical Indicators

Jul 03, 2024, 04:27 PM
Name
Value
Implied Action
RSI (14)
43.45
Neutral
STOCH (9,6)
23.79
Neutral
STOCHRSI (14)
13.94
Buy
MACD (12,26)
-0.05
Buy
ADX (14)
21.80
Neutral
Williams %R
-87.98
Buy
CCI (14)
-96.90
Neutral
ATR (14)
0.16
-
Ultimate Oscillator
41.62
Neutral
ROC
-25.58
Sell
TransCode Therapeutics’s (RNAZ) Relative Strength Index (RSI) is 43.45, creating a Neutral signal.
TransCode Therapeutics’s (RNAZ) Trend Strength Indicator (ADX) is 21.80, creating a Neutral signal.
TransCode Therapeutics’s (RNAZ) Commodity Channel Index (CCI) is -96.90, creating a Neutral signal.
TransCode Therapeutics’s (RNAZ) Price Rate of Change (ROC) is -25.58, creating a Sell signal.

FAQ

Is RNAZ a Buy, Hold, or Sell?
Based on RNAZ’s technical indicators, RNAZ is a Sell.
    What is RNAZ’s RSI (14)?
    RNAZ’s RSI (14) is 43.45, which suggests RNAZ is a Neutral.
      What is RNAZ’s MACD?
      RNAZ’s MACD is -0.05, which suggests RNAZ is a Buy.
        What is RNAZ’s 5-day moving average?
        RNAZ’s 5-day moving average is 1.01, which suggests RNAZ is a Sell.
          What is RNAZ’s 20-day moving average?
          RNAZ 20-day moving average is 1.15, which suggests RNAZ is a Sell.
            What is RNAZ’s 50-day moving average?
            RNAZ’s 50-day moving average is 1.06, which suggests RNAZ is a Sell.
              What is RNAZ’s 200-day moving average?
              RNAZ’s 200-day moving average is 6.49, which suggests RNAZ is a Sell.
                What is RNAZ’s Williams % R (14)?
                RNAZ’s Williams % R (14) is -87.98, which suggests RNAZ is a Buy.
                  What is RNAZ’s CCI (14)?
                  RNAZ’s CCI (14) is -96.90, which suggests RNAZ is a Neutral.
                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis